The MycoTechnology Board of Directors has appointed Dr. Robert Scott as a member of the board.
Dr. Scott is a food and beverage industry executive with 25+ years of leadership experience across corporate, academic, and nonprofit sectors. He is an accomplished innovation leader, bringing new technologies to the market, leading the implementation of strategic initiatives, and driving organisational transformation.
“We are thrilled to welcome Robert to the MycoTechnology Board of Directors,” said Rob Case, Chairman of the Board, MycoTechnology. “Robert’s broad understanding of the food and beverage industry and specifically his beverage category sweetener expertise will be especially valuable as we commercialise and bring to market our revolutionary new ingredient, Honey Truffle Sweet Protein, which is naturally derived from the honey truffle and delivers a uniquely clean taste profile with minimal off-notes.”
“In addition, Robert’s contributions to the board will be important by providing the customer view as we continue to expand our portfolio of natural ingredient solutions from mushroom mycelia fermentation into the global food and beverage markets,” said Jordi Ferre, CEO, MycoTechnology.
Since May 2025, Dr. Scott has been the president of Albany State University (Albany, GA). Previously, he was President, R&D at Kraft Heinz, where he led the transformation of a global R&D organisation through strategic innovation and operational alignment. At Coca-Cola, Dr. Scott was Vice President, R&D, where he led new ingredient discovery, sweetener technology development and led R&D teams in the US, Latin America, Europe, China and Japan. As a Division Vice President at Abbott Nutrition, he was the senior R&D leader accountable for product development. Dr. Scott began his business career at Procter & Gamble. His academic career includes Associate Dean at Spelman College and Boston College, and Assistant Professor of Biology at Norfolk State University.
[Image credit: Dr. Robert Scott]